Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Urology Care Foundation Bridge Award

The Urology Care Foundation Bridge Award, supported by Dornier MedTech, is the AUA’s new initiative to support established urology researchers navigating critical financial shortages. Its goal is simple but impactful: sustain urologic projects that are at risk due to gaps between major grants, required post-peer review revisions, or unexpected laboratory setbacks.

Congratulations to the 2025 Award Winners. 

Emilie Johnson, MD, MPH

Emilie Johnson, MD, MPH

Attending Physician at the Ann & Robert H. Lurie Children’s Hospital of Chicago and Associate Professor at Northwestern University Feinberg School of Medicine

Project Title: “Implementation and Evaluation of SaFE-NC: A Safe, Feasible, and Equitable Newborn Circumcision Program”

Dr. Johnson is a pediatric urologist and health services and outcomes researcher with an interest in minimally invasive surgical techniques, the care of individuals with differences of sex development (DSD/intersex) and understanding and improving the patient experience.

Debasish Sundi, MD

Debasish Sundi, MD

Associate Professor and Urologic Oncologist at The Ohio State University

Project Title: “Urine Derived Lymphocytes as a Biomarker of Therapeutic Response in Bladder Cancer”

Dr. Sundi’s clinical and laboratory focus is on bladder cancer. He has particular interest in the discovery of new immunotherapy targets, defining sex differences in bladder cancer immunology, defining the role of antiandrogen therapy in bladder cancer, and developing non-invasive urine-based immune biomarkers of the tumor immune microenvironemnt. He is also involved in investigating this disease through clinical trials.

advertisement

advertisement